Diabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic. (Q38793134)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27026400%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

title

Diabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27026400%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

main subject

cardiovascular disease

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27026400%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

author name string

P J Grant

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27026400%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

language of work or name

1 reference

1 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27026400%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27026400%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27026400%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

page(s)

184-192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27026400%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27026400%20AND%20SRC:MED&resulttype=core&format=json

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

31 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Association of diabetes with increased all-cause mortality following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the contemporary era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Genetic Syndromes of Severe Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Complement C3 is a risk factor for the development of diabetes: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

The role of nitric oxide in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Inflammatory and thrombotic mechanisms in coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Inflammation and coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Diabetes, glucose toxicity, and oxidative stress: A case of double jeopardy for the pancreatic islet beta cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Inflammatory links between obesity and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Mechanisms linking obesity with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Diabetes mellitus as a prothrombotic condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Endothelial dysfunction: cause of the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Coagulation and atherothrombotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Glycation of fibrinogen in uncontrolled diabetic patients and the effects of glycaemic control on fibrinogen glycation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

The influence of type 2 diabetes on fibrin structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Fibrinolytic activity is highly influenced by long-term glycemic control in Type 1 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Complement C3 is a novel plasma clot component with anti-fibrinolytic properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Platelet inhibition by insulin is absent in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Inflammation and thrombosis in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Aspirin and clopidogrel: efficacy and resistance in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Insulin, insulin resistance and platelet function: similarities with insulin effects on cultured vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Platelet activation in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Cardiovascular outcomes with antihypertensive therapy in type 2 diabetes: an analysis of intervention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Effect of a multifactorial intervention on mortality in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Long-term effects of intensive glucose lowering on cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Altered properties of the fibrin gel structure in patients with IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-016-4414-8

Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation

21 January 2018

1 reference

12 December 2020

Contribution of nitric oxide to metabolic coronary vasodilation in the human heart

1 reference

12 December 2020

Oxidative stress and atherosclerosis

1 reference

12 December 2020

Factor VII gene polymorphisms, factor VII:C levels and features of insulin resistance in non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Glycaemic control improves fibrin network characteristics in type 2 diabetes - a purified fibrinogen model

1 reference

12 December 2020

Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance

1 reference

12 December 2020

Plasminogen-activator inhibitor type 1 and coronary artery disease

1 reference

12 December 2020

Fibrinogen and fibrin clot structure in diabetes

1 reference

12 December 2020

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

12 December 2020

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

12 December 2020

PAI-1 concentrations in first-degree relatives of patients with non-insulin-dependent diabetes: metabolic and genetic associations.

1 reference

12 December 2020

10.1007/S00059-016-4414-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27026400%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference